ADVERSE EVENTS RELATED TO THE USE OF ANTIDEPRESSANTS

Authors

  • Luís Antônio Alves Magalhães UNIPAM
  • Victor Gabriel Reis Pereira de Freitas UNIPAM
  • Juliana Lilis da Silva UNIPAM
  • Natália de Fátima Gonçalves Amâncio UNIPAM

DOI:

https://doi.org/10.36557/2674-8169.2025v7n12p1037-1058

Keywords:

Antidepressants, Side effects, Pharmacovigilance

Abstract

Objectives: This study aims to conduct a literature review on the side effects of antidepressants. Methods: A bibliographic search was carried out covering the period from 2020 to 2025 in the following databases: Google Scholar, Scientific Electronic Library Online (SciELO), and the National Library of Medicine (PubMed). A total of 41 articles were selected; after full-text reading, those whose content did not contribute to the development of this article were excluded. Thus, 29 articles remained and were used in the preparation of the review following careful selection. Results: Five classes of antidepressants and their respective side effects were analyzed. SSRIs are safer compared with older classes but present repercussions such as sexual dysfunction, weight gain, and sweating. SNRIs cause effects such as nausea, dry mouth, tremor, and, in older adults, an increased risk of falls and fractures, especially with duloxetine and venlafaxine. Although equally effective, TCAs have greater toxicity, which may lead patients to discontinue treatment. MAOIs require dietary restrictions involving foods containing the amino acid tyramine and cannot be combined with certain medications due to the risk of dangerous adverse effects. Atypical antidepressants display a more variable profile owing to a lower likelihood of causing a specific side effect, making them a good alternative to better meet patient needs in some situations. Conclusion: The systematic review indicates that although each class of antidepressants has distinct side effects that, if poorly managed, can lead to complications in the patient’s life, there are multiple therapeutic approaches using these medications. It is up to the physician, together with the patient, to decide which option best fits each clinical scenario.

Downloads

Download data is not yet available.

References

ANAGHA, K.; SHIHABUDHEEN, P.; UVAIS, N. A. Side effect profiles of selective serotonin reuptake inhibitors: a cross-sectional study in a naturalistic setting. The Primary Care Companion for CNS Disorders, v. 23, n. 4, p. 35561, 2021.

ANEKWE, Chika V. et al. Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity‐related conditions: A review. Annals of the New York Academy of Sciences, v. 1533, n. 1, p. 145-155, 2024.

ASANO, Hiroto et al. Safety comparisons among monoamine oxidase inhibitors against Parkinson’s disease using FDA adverse event reporting system. Scientific Reports, v. 13, n. 1, p. 19272, 2023.

ATMACA, Murad. Selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives. Neuropsychiatric Disease and Treatment, p. 1043-1050, 2020.

BALDAÇARA, Leonardo; FREITAS, Railson; DE CARVALHO BALDAÇARA, Raquel Prudente. Tricyclic antidepressants: an update. Research, Society and Development, v. 13, n. 4, p. e4413445539-e4413445539, 2024.

BARROS, Landerson Guimarães et al. Estudo bibliográfico sobre as potenciais interações medicamentosas envolvendo antidepressivos tricíclicos. E-Acadêmica, v. 3, n. 2, p. e8232244-e8232244, 2022.

CHAMBERLAIN, Samuel R.; BALDWIN, David S. Monoamine oxidase inhibitors (MAOIs) in psychiatric practice: how to use them safely and effectively. CNS Drugs, v. 35, n. 7, p. 703-716, 2021.

CHU, A.; WADHWA, R. Selective Serotonin Reuptake Inhibitors. StatPearls Publishing, jan. 2025.

CLIATT, Hayley; WILLIAMS, Andrew M.; KOCH, Jessa. Management of antidepressant-induced bruxism. Mental Health Clinician, v. 15, n. 3, p. 147-9, 2025.

EDINOFF, Amber N. et al. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurology International, v. 13, n. 3, p. 387-401, 2021.

GHEYSENS, Tim; VAN DEN EEDE, Filip; DE PICKER, Livia. The risk of antidepressant-induced hyponatremia: A meta-analysis of antidepressant classes and compounds. European Psychiatry, v. 67, n. 1, p. e20, 2024.

GOSMANN, Natan Pereira et al. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis. Psychological Medicine, v. 53, n. 9, p. 3783-3792, 2023.

HENSSLER, Jonathan et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry, v. 11, n. 7, p. 526-535, 2024.

JIANG, Aidou et al. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis. Therapeutic Advances in Drug Safety, v. 15, p. 20420986241244585, 2024.

KAMP, C. B. et al. The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Epidemiology and Psychiatric Sciences, v. 33, p. e51, 2024.

KAMP, Caroline Barkholt et al. Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis. BMJ Mental Health, v. 27, n. 1, 2024.

KAMPANI, A. Adverse effects of antidepressant medications: a comparative analysis of different classes. International Journal of Research in Psychiatry, v. 4, n. 1, p. 21-32, 2024.

KHALID, M. M.; WASEEM, M. Tricyclic Antidepressant Toxicity. StatPearls Publishing, jan. 2025.

LAMER, Antoine et al. Prolonged increase in psychotropic drug use among young women following the COVID-19 pandemic: a French nationwide retrospective study. BMC Medicine, v. 22, n. 1, p. 274, 2024.

LI, Yumeng; DU, Xiaoyu; WU, Huizhen. The risk of hyponatremia induced by SSRIs and SNRIs antidepressants: a systematic review and meta-analysis. BMC Pharmacology and Toxicology, v. 26, n. 1, p. 144, 2025.

MASUKA, Josiah T. et al. Selective serotonin reuptake inhibitor and serotonin‐norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series. Australasian Journal of Dermatology, v. 63, n. 1, p. e13-e20, 2022.

MO, Huan et al. Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research Program. Clinical Pharmacology & Therapeutics, v. 117, n. 2, p. 534-543, 2025.

OKAYASU, Hiroaki et al. The Association Between Antidepressant Treatment and Heart Rate Deceleration Capacity in Patients With Mood disorders—A Potential New Predictor of Sudden Cardiac Death. Neuropsychiatric Disease and Treatment, p. 597-607, 2025.

PAGE, Matthew J. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. bmj, v. 372, 2021.

ROTHMORE, Jody. Antidepressant‐induced sexual dysfunction. Medical Journal of Australia, v. 212, n. 7, 2020.

DA SILVA, Beatriz Aguiar et al. Processos de validação de instrumentos para área da saúde. Revista Eletrônica Acervo Saúde, v. 24, n. 2, p. e14695-e14695, 2024.

SUB LABAN, T.; SAADABADI, A. Monoamine Oxidase Inhibitors (MAOI). StatPearls Publishing, jan. 2025.

SUCHTING, Robert et al. Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: A systematic review and network meta-analysis. Journal of Affective Disorders, v. 282, p. 1153-1160, 2021.

TABAH, Ashley et al. Antidepressants and the risk of fall-related injury in older adults with incident depression in the United States: a comparative safety analysis. Pharmacoepidemiology, v. 2, n. 3, p. 209-222, 2023.

WANG, Ke et al. Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience, v. 15, p. 1134472, 2023.

WANG, Zhuoyue et al. Risks of digestive system side-effects of selective serotonin reuptake inhibitors in patients with depression: a network meta-analysis. Therapeutics and Clinical Risk Management, p. 799-812, 2022

Published

2025-12-15

How to Cite

Alves Magalhães, L. A., Reis Pereira de Freitas, V. G., Lilis da Silva, J., & de Fátima Gonçalves Amâncio, N. (2025). ADVERSE EVENTS RELATED TO THE USE OF ANTIDEPRESSANTS. Brazilian Journal of Implantology and Health Sciences, 7(12), 1037–1058. https://doi.org/10.36557/2674-8169.2025v7n12p1037-1058